[{"title": "Finding the right needle in the haystack: the real challenge of AF screening", "link": "https://pubmed.ncbi.nlm.nih.gov/39227000/", "details": "X Yao, PA Noseworthy - Journal of the American College of Cardiology, 2024", "abstract": ""}, {"title": "Ten quick tips for electrocardiogram (ECG) signal processing", "link": "https://peerj.com/articles/cs-2295/", "details": "D Chicco, AI Karaiskou, M De Vos - PeerJ Computer Science, 2024", "abstract": "The electrocardiogram (ECG) is a powerful tool to measure the electrical activity of the heart, and the analysis of its data can be useful to assess the patient's health. In particular, the computational analysis of electrocardiogram data, also called ECG \u2026"}, {"title": "Long term safety and outcomes after atrial shunting for heart failure with preserved or mildly reduced ejection fraction: 5-year and 3-year follow-up in the REDUCE \u2026", "link": "https://www.sciencedirect.com/science/article/pii/S0002870324002163", "details": "SE Litwin, J Komtebedde, BA Borlaug, DM Kaye\u2026 - American Heart Journal, 2024", "abstract": "Background There is a little evidence regarding long-term safety and efficacy for atrial shunt devices in heart failure (HF). Methods The REDUCE LAP-HF I (n= 44) and II (n= 621) trials (RCT-I and-II) were multicenter, randomized, sham-controlled \u2026"}, {"title": "Independent risk factors of left ventricular hypertrophy in non-diabetic individuals in Sierra Leone-a cross-sectional study", "link": "https://link.springer.com/article/10.1186/s12944-024-02232-8", "details": "Y Xu, YC Jiang, L Xu, W Zhou, Z Zhang, Y Qi, H Kuang\u2026 - Lipids in Health and \u2026, 2024", "abstract": "Background Left ventricular hypertrophy (LVH) is a critical factor in heart failure and cardiovascular event-related mortality. While the prevalence of LVH in diabetic patients is well-documented, its occurrence and risk factors in non-diabetic \u2026"}]
